Table 4.
Demographic information. Normally distributed variables are reported as mean ± standard deviation
| MSA all | MSA-C | MSA-P | P-value MSA-C vs MSA-P | |
|---|---|---|---|---|
| Sample size | 36 | 25 | 11 | |
| Age at BL | 60.6 ± 6.4 | 60.9 ± 5.9 | 59.7 ± 7.7 | 0.6a |
| Sex | 18 F/18 M | 12 F/13 M | 6 F/5 M | >0.9b |
| FUP time (years) | 0.96 (0.20) | 0.97 (0.19) | 0.97 ± 0.14 | 0.9a |
| MCI status at BL | 20 no/16 yes | 13 no/12 yes | 7 no/4 yes | 0.7b |
| Disease duration (years) | 3 (2) | 3.0 ± 1.4 | 2.9 ± 1.3 | 0.8c |
| UMSARS-I at BL | 19.1 ± 5.2 | 18.2 ± 4.3 | 21.2 ± 6.6 | 0.1c |
| UMSARS-I at FUP | 25.0 ± 5.9 | 24.6 ± 5.1 | 26.0 ± 7.4 | 0.5c |
| HC | P-value HC vs MSA | |||
| Sample Size | 50 | |||
| Age | 63.9 ± 9.2 | 0.07a | ||
| Sex | 26 F/24 M | >0.9b |
Non-normally distributed variables are reported as median (interquartile range).
BL baseline, FUP follow-up, MCI Mild Cognitive Impairment, UMSARS-I Unified Multiple System Atrophy Rating Scale Part I, HC healthy controls.
aT-test.
bexact Fisher test for categorical variables.
cMann-Whitney U test.